Advanced Medical Solutions Group (AMS)

Sector:

Health Care

Index:

FTSE AIM 50

196.00p
   
  • Change Today:
      6.00p
  • 52 Week High: 258.00
  • 52 Week Low: 177.20
  • Currency: UK Pounds
  • Shares Issued: 217.34m
  • Volume: 675,229
  • Market Cap: £425.99m
  • RiskGrade: 156

Advanced Medical Solutions gets CE-mark for Seal-G MIST

By Josh White

Date: Tuesday 20 Apr 2021

LONDON (ShareCast) - (Sharecast News) - Surgical and advanced wound care-focussed Advanced Medical Solutions has received CE-mark approval for its laparoscopic gastrointestinal sealant device 'Seal-G MIST', it announced on Tuesday.
The AIM-traded firm said that the existing CE-mark for the 'Seal-G' open device had also been extended to include a blue colourant, to aid visibility for the surgeon during product usage.

Patient enrolment for the first human clinical study of Seal-G and Seal-G MIST began in Israel in February, with a small number of patient procedures and successful follow-ups already complete.

The 160-patient study would also recruit patients in the UK and Italy, with final study results expected in early 2022.

Advanced Medical Solutions said the open-label trial would collect clinical evidence on the usage, safety, performance and usability of Seal-G and Seal-G MIST.

Successful study results would provide additional momentum for the full commercial Europe launch, planned for 2022.

In 2020, the company completed commercial research activity with 'key opinion leaders' in Europe for both products.

Positive feedback was received, including recognition that the device was a "potential solution" to the unmet need for an effective gastrointestinal sealant.

"Having invested in these innovative products since acquiring Sealantis in January 2019, we are busy preparing to enter the global $1bn internal sealants market with a differentiated commercial product range," said chief executive officer Chris Meredith.

"These market approvals and the initiation of patient enrolment are important milestones for the group as we continue to build our commercial activity through 2021, in anticipation of full commercial launch in 2022."

At 0953 BST, shares in Advanced Medical Solutions Group were up 1.1% at 275p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AMS Market Data

Currency UK Pounds
Share Price 196.00p
Change Today 6.00p
% Change 3.16 %
52 Week High 258.00
52 Week Low 177.20
Volume 675,229
Shares Issued 217.34m
Market Cap £425.99m
RiskGrade 156

AMS Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
69.71% below the market average69.71% below the market average69.71% below the market average69.71% below the market average69.71% below the market average
37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average37.50% above the sector average
Price Trend
28% below the market average28% below the market average28% below the market average28% below the market average28% below the market average
13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average13.51% above the sector average
Income
85.62% below the market average85.62% below the market average85.62% below the market average85.62% below the market average85.62% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
42.31% below the market average42.31% below the market average42.31% below the market average42.31% below the market average42.31% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 2
Sell 1
Strong Sell 0
Total 9
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AMS Dividends

  Latest Previous
  Final Interim
Ex-Div 30-May-24 28-Sep-23
Paid 21-Jun-24 27-Oct-23
Amount 1.66p 0.70p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 55,643 @ 196.00p
16:35 1 @ 196.00p
16:35 342 @ 196.00p
16:35 43 @ 196.00p
16:35 196 @ 196.00p

AMS Key Personnel

CEO A Christopher (Chris) Meredith
CFO Eddie Johnson
Chair Liz Shanahan

Top of Page